Armistice Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kraft Heinz
KHC
|
+$43.2M |
| 2 |
Biogen
BIIB
|
+$27.9M |
| 3 |
O'Reilly Automotive
ORLY
|
+$26.2M |
| 4 |
VF Corp
VFC
|
+$24.3M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFRG
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
|
+$48.8M |
| 2 |
Edgewell Personal Care
EPC
|
+$46M |
| 3 |
Burlington
BURL
|
+$38.1M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
+$28.1M |
| 5 |
RH
RH
|
+$25.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.4% |
| 2 | Consumer Discretionary | 17.83% |
| 3 | Consumer Staples | 5.02% |
| 4 | Industrials | 4.83% |
| 5 | Technology | 1.69% |
Similar funds
Armistice Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Armistice Capital held 89 positions worth $1.51B, down 4.9% from $1.59B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Armistice Capital withdrew a net $382M in Q3 2019, closing 23 positions and reducing 17 holdings. Its most notable exit was Del Frisco's Restaurant Group, Inc. Common Stock, an estimated $48.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
Against the trend, Armistice Capital opened a new position in Kraft Heinz worth $41.9M.
- Armistice Capital's largest Q3 2019 buy was Kraft Heinz: 1,500,000 shares worth $41.9M.
- Armistice Capital added most to Biogen in Q3 2019, an estimated $27.9M increase.
- Armistice Capital's biggest Q3 2019 reduction was Madrigal Pharmaceuticals, cutting an estimated $28.1M.
- Armistice Capital fully exited Del Frisco's Restaurant Group, Inc. Common Stock in Q3 2019, selling an estimated $48.8M.
- Armistice Capital's ten largest holdings make up 47% of its $1.51B portfolio in Q3 2019.
- Armistice Capital opened 28 new positions and closed 23 in Q3 2019.
- Armistice Capital's portfolio value fell 4.9% quarter-over-quarter to $1.51B.
Based on Armistice Capital's 13F filing for Q3 2019, filed 14 Nov 2019.